Global CRO laboratories provide regulatory-ready biomarker data across immunology, histopathology, proteomics, and genomics. They partner with biopharma and biotech companies to generate the reliable data needed to advance programs across the full clinical development journey — from translational research through clinical development and companion diagnostic (CDx). CROs are always looking for ways to streamline their operations, harmonize data gathered across multiple sites, and maximize their insights from a single tissue section.
In this application note from Bio-Techne, Patrick Reese, VP of Operations for CellCarta's US Histopathology Services, talks about a fully automated, high-throughput spatial biology and hyperplexing platform that opens the door to “guided exploration” of novel markers.